Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer. J. Anal. Oncol. 2015, 4 (1),  44-51. https://doi.org/10.6000/1927-7229.2015.04.01.8.